Market Place
Sourcing Support
VectorY Appoints Jim Scibetta as New CEO
16 Dec 2024 //
BUSINESSWIRE
UMC Utrecht And VectorY Collaborate In ALS Biomarker Study
17 Jun 2024 //
BUSINESSWIRE
VectorY Appoints Khurem Farooq to Board of Directors
18 Jan 2024 //
BUSINESSWIRE
VectorY Raises €129 Million ($138 Million) Series A Financing
13 Nov 2023 //
BUSINESSWIRE
VectorY raises $138M to push forward ALS program
13 Nov 2023 //
FIERCE BIOTECH
VectorY and Annogen Announce Collaboration for CNS-cell Specific Promoters
19 Jan 2023 //
BUSINESSWIRE
VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments
08 Nov 2022 //
BUSINESSWIRE
VectorY Appoints Sander van Deventer as CEO
08 Nov 2022 //
BUSINESSWIRE
VectorY Announces Participation in Scientific Conferences in October 2022
06 Oct 2022 //
BUSINESSWIRE
VectorY to Present on Huntington’s PC Data at Hereditary Disease Foundation
23 Aug 2022 //
BUSINESSWIRE
VectorY presents pre-clinical data at the European Network for the Cure of ALS
02 Jun 2022 //
BUSINESSWIRE
VectorY Announces Preclinical Data on TDP-43 and Oxidized Phospholipids
18 May 2022 //
BUSINESSWIRE
VectorY to Present Two Posters at the ASGCT 25th Annual Meeting
11 May 2022 //
BUSINESSWIRE
VectorY, Wageningen University Collaborate for Baculovirus-based Technologies
25 Jan 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.